written on 27.02.2014
Tags:
,

The Most Promising Drugs to Watch Changing Phase and Receiving Approval Q4 2013

TAGS: ,

The latest The Ones to Watch report is an expert review of the most promising drugs to watch launched from October to December 2013. These pharmaceuticals are changing clinical phase and receiving approval based on the strategic data and insight of Thomson Reuters Cortellisâ„¢ for Competitive Intelligence, an advanced source for timely and accurate Life […]

Latest Report